Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines

Human Molecular Genetics

Volumn 22, Issue 19, 2013, Pages 3931-3946

  Silva, Diana F ^a   Selfridge, J Eva ^c   Lu, Jianghua ^c   Lezi, E ^c   Roy, Nairita ^c   Hutfles, Lewis ^d   Burns, Jeffrey M ^c,d   Michaelis, Elias K ^d,e   Yan, ShiDu ^e   Cardoso, Sandra M ^a,b   Swerdlow, Russell H ^c,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CYTOCHROME C OXIDASE; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BAX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 1;

ALZHEIMER DISEASE; ANAEROBIC GLYCOLYSIS; ARTICLE; BIOENERGY; CELL STRUCTURE; CONTROLLED STUDY; CYBRID; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; HUMAN CELL; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MODIFIER GENE; OXYGEN CONSUMPTION; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMP-ACTIVATED PROTEIN KINASES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE; DNA, MITOCHONDRIAL; ENERGY METABOLISM; HUMANS; HYBRID CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; SIRTUIN 1; TOR SERINE-THREONINE KINASES;

EID: 84888799219     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt247     Document Type: Article

References (81)

1. Swerdlow, R.H. (2012) Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid. Redox Signal., 16, 1434-1455.
2. Valla, J., Schneider, L., Niedzielko, T., Coon, K.D., Caselli, R., Sabbagh, M.N., Ahern, G.L., Baxter, L., Alexander, G., Walker, D.G. et al. (2006) Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion, 6, 323-330.
3. Petersen, R.C. (2011) Clinical practice. Mild cognitive impairment. N. Engl. J. Med., 364, 2227-2234.
4. Pellerin, L. and Magistretti, P.J. (2003) Food for thought: challenging the dogmas. J. Cereb. Blood Flow Metab., 23, 1282-1286.
5. Swerdlow, R.H., Burns, J.M. and Khan, S.M. (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J. Alzheimers Dis., 20, S265-S279.
6. Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R.L., Atwood, C.S., Johnson, A.B., Kress, Y., Vinters, H.V., Tabaton, M. et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci., 21, 3017-3023.
7. Nixon, R.A. (2007) Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci., 120, 4081-4091.
8. Henriques, A.G., Vieira, S.I., da Cruz, E.S.E.F. and da Cruz, E.S.O.A. (2010) Abeta promotes Alzheimer's disease-like cytoskeleton abnormalities with consequences to APP processing in neurons. J. Neurochem., 113, 761-771.
9. Silva, D.F., Esteves, A.R., Arduino, D.M., Oliveira, C.R. and Cardoso, S.M. (2011) Amyloid-beta-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway. J. Alzheimers Dis., 26, 565-581.
10. de la Monte, S.M., Luong, T., Neely, T.R., Robinson, D. and Wands, J.R. (2000) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest., 80, 1323-1335.
11. Nagy, Z., Esiri, M.M., LeGris,M. and Matthews, P.M. (1999) Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol., 97, 346-354.
12. Su, B., Wang, X., Bonda, D., Perry, G., Smith, M. and Zhu, X. (2010) Abnormal mitochondrial dynamics-a novel therapeutic target for Alzheimer's disease? Mol. Neurobiol., 41, 87-96.
13. Santos, R.X., Correia, S.C., Wang, X., Perry, G., Smith, M.A., Moreira, P.I. and Zhu, X. (2010)Asynergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J. Alzheimers Dis., 20, S401-S412.
14. Hoppins, S., Lackner, L. and Nunnari, J. (2007) The machines that divide and fuse mitochondria. Annu. Rev. Biochem., 76, 751-780.
15. Wang, X., Su, B., Lee, H.G., Li, X., Perry, G., Smith, M.A. and Zhu, X. (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci., 29, 9090-9103.
16. Manczak, M., Calkins, M.J. and Reddy, P.H. (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet., 20, 2495-2509.
17. Wang, X., Su, B., Siedlak, S.L., Moreira, P.I., Fujioka, H., Wang, Y., Casadesus, G. and Zhu, X. (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl Acad. Sci. USA, 105, 19318-19323.
18. Twig, G. and Shirihai, O.S. (2011) The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal., 14, 1939-1951.
19. Silva, D.F., Santana, I., Esteves, A.R., Baldeiras, I., Arduino, D.M., Oliveira, C.R. and Cardoso, S.M. (2012) Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimers disease. Curr. Alzheimer Res., 10, 180-190.
20. Trimmer, P.A., Keeney, P.M., Borland, M.K., Simon, F.A., Almeida, J., Swerdlow, R.H., Parks, J.P., Parker, W.D. Jr and Bennett, J.P. Jr. (2004) Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol. Dis., 15, 29-39.
21. Cardoso, S.M., Santana, I., Swerdlow, R.H. and Oliveira, C.R. (2004) Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem., 89, 1417-1426.
22. Semenza, G.L. (2012) Hypoxia-inducible factors in physiology and medicine. Cell, 148, 399-408.
23. Handschin, C. and Spiegelman, B.M. (2006) Peroxisome proliferatoractivated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev., 27, 728-735.
24. Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., Troconso, J.C., Dawson, V.L. and Dawson, T.M. (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell, 144, 689-702.
25. Canto, C. and Auwerx, J. (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol., 20, 98-105.
26. Nemoto, S., Fergusson, M.M. and Finkel, T. (2005) SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem., 280, 16456-16460.
27. Jager, S., Handschin, C., St-Pierre, J. and Spiegelman, B.M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl Acad. Sci. USA, 104, 12017-12022.
28. Feige, J.N. and Auwerx, J. (2007) Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol., 17, 292-301.
29. Onyango, I.G., Ahn, J.Y., Tuttle, J.B., Bennett, J.P. Jr and Swerdlow, R.H. (2010) Nerve growth factor attenuates oxidant-induced beta-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids. J. Neurochem., 114, 1605-1618.
30. Onyango, I.G., Tuttle, J.B. and Bennett, J.P. Jr. (2005) Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Mol. Cell Neurosci., 29, 333-343.
31. Scarpulla, R.C. (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev., 88, 611-638.
32. Chan, D.C. (2006) Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol., 22, 79-99.
33. Chen, H. and Chan, D.C. (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet., 18, R169-R176.
34. Cereghetti, G.M., Stangherlin, A., Martins de Brito, O., Chang, C.R., Blackstone, C., Bernardi, P. and Scorrano, L. (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl Acad. Sci. USA, 105, 15803-15808.
35. Cereghetti, G.M., Costa, V. and Scorrano, L. (2010) Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ., 17, 1785-1794.
36. Cho, S.G., Du, Q., Huang, S. and Dong, Z. (2010) Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. Am. J. Physiol. Renal Physiol., 299, F199-F206.
37. Autret, A. and Martin, S.J. (2010) Bcl-2 family proteins and mitochondrial fission/fusion dynamics. Cell Mol. Life Sci., 67, 1599-1606.
38. Sheridan, C., Delivani, P., Cullen, S.P. and Martin, S.J. (2008) Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol. Cell, 31, 570-585.
39. Cunningham, J.T., Rodgers, J.T., Arlow, D.H., Vazquez, F., Mootha, V.K. and Puigserver, P. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature, 450, 736-740.
40. Schieke, S.M., Phillips, D., McCoy, J.P. Jr, Aponte, A.M., Shen, R.F., Balaban, R.S. and Finkel, T. (2006) The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem., 281, 27643-27652.
41. Stephan, B.C., Hunter, S., Harris, D., Llewellyn, D.J., Siervo, M., Matthews, F.E. and Brayne, C. (2012) The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol. Psychiatry, 17, 1056-1076.
42. Parker, W.D. Jr, Filley, C.M. and Parks, J.K. (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
43. Swerdlow, R.H., Parks, J.K., Cassarino, D.S., Maguire, D.J., Maguire, R.S., Bennett, J.P. Jr, Davis, R.E. and Parker, W.D. Jr. (1997) Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology, 49, 918-925.
44. Soucek, T., Cumming, R., Dargusch, R., Maher, P. and Schubert, D. (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron, 39, 43-56.
45. Silverman, D.H., Small, G.W., Chang, C.Y., Lu, C.S., Kung De Aburto, M.A., Chen, W., Czernin, J., Rapoport, S.I., Pietrini, P., Alexander, G.E. et al. (2001) Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA, 286, 2120-2127.
46. Matsuda, H. (2007) The role of neuroimaging in mild cognitive impairment. Neuropathology, 27, 570-577.
47. Semenza, G.L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol., 15, 551-578.
48. Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I. and Gong, C.X. (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett., 582, 359-364.
49. Grammas, P., Samany, P.G. and Thirumangalakudi, L. (2006) Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J. Alzheimers Dis., 9, 51-58.
50. Qin, W., Haroutunian, V., Katsel, P., Cardozo, C.P., Ho, L., Buxbaum, J.D. and Pasinetti, G.M. (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol., 66, 352-361.
51. Sheng, B., Wang, X., Su, B., Lee, H.G., Casadesus, G., Perry, G. and Zhu, X. (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem., 120, 419-429.
52. Vercauteren, K., Pasko, R.A., Gleyzer, N., Marino, V.M. and Scarpulla, R.C. (2006) PGC-1-related coactivator: immediate early expression and characterization of a CREB/NRF-1 binding domain associated with cytochrome c promoter occupancy and respiratory growth. Mol. Cell Biol., 26, 7409-7419.
53. Swerdlow, R.H. (2012) beta-Apptists and Tauists, it is time for a sermon from the book of biogenesis. J. Neurochem., 120, 347-349.
54. Jin, Q., Yan, T., Ge, X., Sun, C., Shi, X. and Zhai, Q. (2007) Cytoplasm-localized SIRT1 enhances apoptosis. J. Cell Physiol., 213, 88-97.
55. Piantadosi, C.A. and Suliman, H.B. (2012) Redox regulation of mitochondrial biogenesis. Free Radic. Biol. Med., 53, 2043-2053.
56. Hensley, K., Floyd, R.A., Zheng, N.Y., Nael, R., Robinson, K.A., Nguyen, X., Pye, Q.N., Stewart, C.A., Geddes, J., Markesbery, W.R. et al. (1999) p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem., 72, 2053-2058.
57. Sun, A., Liu, M., Nguyen, X.V. and Bing, G. (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp. Neurol., 183, 394-405.
58. Vingtdeux, V., Davies, P., Dickson,D.W. and Marambaud, P. (2011)AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropath., 121, 337-349.
59. Julien, C., Tremblay, C., Emond, V., Lebbadi, M., Salem, N. Jr, Bennett, D.A. and Calon, F. (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol., 68, 48-58.
60. Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H. and Hiltunen, M. (2011) AMP-activated protein kinase: a potential player in Alzheimer's disease. J. Neurochem., 118, 460-474.
61. Hands, S.L., Proud, C.G. and Wyttenbach, A. (2009)mTOR'srole in ageing: protein synthesis or autophagy? Aging, 1, 586-597.
62. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J. et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet., 36, 585-595.
63. Li, X., Alafuzoff, I., Soininen, H., Winblad, B. and Pei, J.J. (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J., 272, 4211-4220.
64. Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H. and Nixon, R.A. (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci., 28, 6926-6937.
65. Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A. and Cuervo, A.M. (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol., 64, 113-122.
66. Mizushima, N., Levine, B., Cuervo, A.M. and Klionsky, D.J. (2008) Autophagy fights disease through cellular self-digestion. Nature, 451, 1069-1075.
67. Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G., Stiles, L., Haigh, S.E., Katz, S., Las, G. et al. (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J., 27, 433-446.
68. Brown, A.M., Sheu, R.K., Mohs, R., Haroutunian, V. and Blass, J.P. (2001) Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA). J. Mol. Neurosci., 16, 41-48.
69. Coskun, P.E., Beal, M.F. and Wallace, D.C. (2004) Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl Acad. Sci. USA, 101, 10726-10731.
70. Rodriguez-Santiago, B., Casademont, J. and Nunes, V. (2001) Is mitochondrial DNA depletion involved in Alzheimer's disease? Eur. J. Hum. Genet., 9, 279-285.
71. Baloyannis, S.J. (2006) Mitochondrial alterations in Alzheimer's disease. J. Alzheimers Dis., 9, 119-126.
72. Baloyannis, S.J. (2011) Mitochondria are related to synaptic pathology in Alzheimer's disease. Int. J. Alzheimers Dis., 2011, 305395.
73. Manczak, M., Park, B.S., Jung, Y. and Reddy, P.H. (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med., 5, 147-162.
74. Morris, J.C., Storandt, M., Miller, J.P., McKeel, D.W., Price, J.L., Rubin, E.H. and Berg, L. (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol., 58, 397-405.
75. Swerdlow, R.H. and Khan, S.M. (2009) The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp. Neurol., 218, 308-315.
76. Swerdlow, R.H. and Khan, S.M. (2004) A 'mitochondrial cascade hypothesis' for sporadic Alzheimer's disease. Med. Hypotheses, 63, 8-20.
77. Swerdlow, R.H. (2007) Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J. Neurosci. Res., 85, 3416-3428.
78. Lu, J., Wang, K., Rodova, M., Esteves, R., Berry, D., E, L., Crafter, A., Barrett, M., Cardoso, S.M., Onyango, I. et al. (2010) Polymorphic variation in cytochrome oxidase subunit genes. J. Alzheimers Dis., 21, 141-154.
79. Swerdlow, R.H. (2011) Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. Curr. Pharm. Des., 17, 3356-3373.
80. Miller, S.W., Trimmer, P.A., Parker, W.D. Jr and Davis, R.E. (1996) Creation and characterization of mitochondrial DNA-depleted cell lines with ?neuronal-like' properties. J. Neurochem., 67, 1897-1907.
81. Swerdlow, R.H., Parks, J.K., Miller, S.W., Tuttle, J.B., Trimmer, P.A., Sheehan, J.P., Bennett, J.P. Jr, Davis, R.E. and Parker,W.D.Jr. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol., 40, 663-671.